SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-147819
Filing Date
2021-12-09
Accepted
2021-12-09 06:01:35
Documents
13
Period of Report
2021-12-08
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134944d1_8k.htm   iXBRL 8-K 33950
  Complete submission text file 0001104659-21-147819.txt   257159

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA toi-20211208.xsd EX-101.SCH 3537
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toi-20211208_def.xml EX-101.DEF 26805
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE toi-20211208_lab.xml EX-101.LAB 36914
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toi-20211208_pre.xml EX-101.PRE 25423
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2134944d1_8k_htm.xml XML 5450
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 211480192
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine